Xin Su
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hormonal Regulation and Hypertension
-
- Effects and risks of endocrine disrupting chemicals
- Toxic Organic Pollutants Impact
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Hormonal Regulation and Hypertension 5
Xin Su
53 papers receiving 664 citations
Peers
Comparison fields: 5 of 84
- Endocrinology, Diabetes and Metabolism 196
- Health, Toxicology and Mutagenesis 102
- Cancer Research 103
- Orthopedics and Sports Medicine 54
- Cardiology and Cardiovascular Medicine 91
Countries citing papers authored by Xin Su
This map shows the geographic impact of Xin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Su more than expected).
Fields of papers citing papers by Xin Su
This network shows the impact of papers produced by Xin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Su. The network helps show where Xin Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xin Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 24 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 10 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 0 | |
| 16 | 2021 | 5 | |
| 17 | 2018 | 36 | |
| 18 | 2017 | 24 | |
| 19 | 2015 | 3 | |
| 20 | 2009 | 41 |
About Xin Su
Xin Su is a scholar working on Endocrinology, Diabetes and Metabolism, Tourism, Leisure and Hospitality Management, Health, Toxicology and Mutagenesis, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 60 papers that have together received 674 indexed citations. Recurring topics across this work include Effects and risks of endocrine disrupting chemicals (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Toxic Organic Pollutants Impact (6 papers), Estrogen and related hormone effects (6 papers), Bone Metabolism and Diseases (6 papers), Lipoproteins and Cardiovascular Health (5 papers), Hormonal Regulation and Hypertension (5 papers) and Adrenal and Paraganglionic Tumors (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (196 citations), Health, Toxicology and Mutagenesis (102 citations), Cancer Research (103 citations), Orthopedics and Sports Medicine (54 citations) and Cardiology and Cardiovascular Medicine (91 citations). Xin Su has collaborated with scholars based in China, Australia and Germany. Frequent co-authors include Daoquan Peng, Xiang‐Hang Luo, Dongyan Huang, Yi Wen Kong, Han Yan, Yuyu Chou, Jin Ma, Yong Zhong, Ling‐Qing Yuan and E.-Y. Liao. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, Lipids in Health and Disease, Toxicology and Industrial Health and Hormone and Metabolic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.